Ann: Publication of Abstracts for ASCO 2023 Annual Meeting, page-27

Its nothing to get excited about this is 100% business as usual around here. The share price pumps on news and then is dropped like a hot potato. Once that pattern sets in then every trader is trying to beat the next trader to be the first out on every spike.
The ONLY way this is going to change is if institutional buyers come into the stock significantly. So far they haven’t done that. The only reason I can see is they haven’t rated the management here, because results are good and the potential high.

If the company can’t get a good deal done now on the back of the latest round of news and moving into multiple registrational trials then I guess that would confirm they are completes hopeless at the business side of things. But how do you clean the management out?

Lets hope they get it done. Because one more big dilution event with nothing to show for it is going to be very hard to swallow from everyone here.